Generics
Viatris names new chief legal officer
4 February 2026 - Global healthcare company Viatris Inc (Nasdaq:VTRS) announced on Tuesday the appointment of Matthew J Maletta as chief legal officer (CLO), effective 9 February 2026.This follows the...
Alvotech signs biosimilar supply and commercialisation deals with Sandoz
2 February 2026 -

Global biotechnology company Alvotech (NASDAQ: ALVO), which develops and manufactures biosimilar medicines, said on Monday it ha...

InSysBio agrees new collaborative project with BeOne Medicines
29 January 2026 - Quantitative Systems Pharmacology (QSP) modelling specialist InSysBio announced on Wednesday an extension of its collaboration with oncology company BeOne Medicines.In this project, ...
MS Pharma enters strategic partnership with Hetero Group
27 January 2026 - MS Pharma Group, a Jordan-based pharmaceutical company, announced on Monday that it has entered into a strategic partnership with Hetero Group, a manufacturer of Active Pharmaceutica...
Apiject to open new generic injectable drug manufacturing facility in Apex, NC
19 January 2026 - Healthcare technology company Apiject Holdings Inc announced on Friday that it has signed a lease for a 30,000-square-foot pharmaceutical manufacturing facility in Apex, North Caroli...
Sun Pharma announces US availability of UNLOXCYT (cosibelimab-ipdl) for advanced cutaneous squamous cell carcinoma
16 January 2026 - Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA, BSE:524715), an India-based specialty generic drug company, announced on Thursday that UNLOXCYT (cosibelimab-ipdl) is now availa...